LEUKEMIA, B-CELL
Clinical trials for LEUKEMIA, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, B-CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough blood cancers: experimental drug MGD024 enters human testing
Disease control Recruiting nowThis early-stage trial tests a new drug called MGD024 in people with certain blood cancers (like leukemia and lymphoma) that came back or didn't get better with standard treatments. The main goal is to find a safe dose and understand side effects. About 130 adults will receive th…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated May 26, 2026 08:28 UTC
-
New targeted drug pirtobrutinib takes on ibrutinib in major blood cancer trial
Disease control Recruiting nowThis study compares a newer targeted drug, pirtobrutinib, to an older one, ibrutinib, in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). About 662 participants will be enrolled, some who have had prior treatment and some who have not. The goal …
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE3 • Sponsor: Loxo Oncology, Inc. • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
Triple-targeting CAR-T cells aim to outsmart stubborn leukemia
Disease control Recruiting nowThis study tests a new treatment for children and young adults (ages 1-25) with B-cell acute lymphoblastic leukemia (ALL) that has come back or not responded to standard therapy. The treatment uses the patient's own immune cells (T cells) that are modified in the lab to recognize…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC